MiracleCord competitorsClear all

MiracleCord's top competitors include Bio-Path Holdings, ImmunoCellular Therapeutics, Humanigen and TrovaGene.
MiracleCord
MiracleCord
MiracleCord provides baby cord blood banking services.
Bio-Path Holdings
Bio-Path Holdings
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
Humanigen
Humanigen
Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.
TrovaGene
TrovaGene
Trovagene is a clinical-stage, precision medicine oncology therapeutics company.
Founding Date
Founding Date
1997
Founding Date
2007
Founding Date
2006
Founding Date
2000
Founding Date
1999
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Chicago, US HQ
Locations
Bellaire, US HQ
Locations
Calabasas, US HQ
Locations
Brisbane, US HQ
Locations
San Diego, US HQ
Employees
Employees
1
Employees
811% decrease
Employees
357% decrease
Employees
325% decrease
Employees
1229% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
66.3 k
Valuation ($)
9.2 m
Valuation ($)
86.7 m
Valuation ($)
14.8 m
Twitter followers
Twitter followers
80
Twitter followers
N/A
Twitter followers
644
Twitter followers
N/A
Twitter followers
724
Number of tweets (last 30 days)
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
1520286
Alexa Website Rank
527351
Alexa Website Rank
904056
Alexa Website Rank
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$378.3k (FY, 2018)
Net income
Net income
N/A
Net income
($8.6m) (FY, 2018)
Net income
($14.3m) (FY, 2017)
Net income
($12m) (FY, 2018)
Net income
($16.5m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 200k
Total funding raised
$ 2.3m
Total funding raised
$ 32.5m
Total funding raised
$ 124.2m
Total funding raised
$ 34m
For sources of this data, please see the company profile

View company profiles

Bio-Path Holdings
HQ
Bellaire, US
Employees
8↓ 11% decrease

Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.

View company
ImmunoCellular Therapeutics
HQ
Calabasas, US
Employees
3

ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.

View company
Humanigen
HQ
Brisbane, US
Employees
3↓ 25% decrease

Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.

View company
TrovaGene
HQ
San Diego, US
Employees
12↓ 29% decrease

Trovagene is a clinical-stage, precision medicine oncology therapeutics company.

View company